- $6.30m
- -$9.89m
Annual income statement for NuCana, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 26.7 | 36.4 | 47.9 | 39.1 | 32.8 |
Operating Profit | -26.7 | -36.4 | -47.9 | -39.1 | -32.8 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -25.7 | -36.2 | -47.8 | -38.5 | -32 |
Provision for Income Taxes | |||||
Net Income After Taxes | -21.4 | -30.7 | -40.5 | -32 | -27.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -21.4 | -30.7 | -40.5 | -32 | -27.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -21.4 | -30.7 | -40.5 | -32 | -27.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -16.5 | -20.2 | -18.6 | -15.2 | -13 |